Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: Doug Bean who wrote (1569)	12/28/1999 5:02:00 PM
From: vestor	Read Replies (1) \| Respond to of 1837

Am kind of surprised that TA does not seek to come out with info given that Solvay is to purchase again by 12/31 for $9. share. In the last two years the best time to have bought DRMD was Nov and Dec and each time in January the stock share price appreciated. Perhaps when the deferred sales of "C" are included in the next qtrly report coupled with a 1.25 "C" approval will propel the stock price. Certainly I see continued market penetration of "C" and APRI and see no reason why that would not continue. With today being the last possible day for tax loss selling we may have seen the bottom.A profitable qtr. and some insider buying could propel this company back to double digits. There are a lot patents expiring in 2000 and lets hope that DRMD will diligently pursue some of them.